GlassScriptPhysician profile
Nickolas Jae Nahm
NPI 1780944330
$6,843.87
in general payments reported to CMS, 2019-2025
7 companies · $2,154 in 2025
The $2,154 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $33.66 · 2021: $178 · 2022: $756 · 2023: $492 · 2024: $1,753 · 2025: $2,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,550 · Consulting Fee: $492 · Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,550.41 |
| Consulting Fee | $491.78 |
| Food and Beverage | $357.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,602.21 | 2024-2025 | Truelok, Tl-Hex Truelok Hexapod System |
| Medical Device Business Services, INC. | $1,645.03 | 2021-2025 | Na |
| Stryker Corporation | $1,476.99 | 2019 | |
| Biomarin Pharmaceutical INC. | $491.78 | 2023 | |
| Orthopediatrics Corp. | $491.32 | 2022 | |
| Depuy Synthes Sales INC. | $102.88 | 2021-2022 | |
| Medtronic USA, INC. | $33.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickolas Nahm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.